1,261
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Acyclovir-loaded sorbitan esters-based organogel: development and rheological characterization

Pages 551-559 | Received 26 Nov 2015, Accepted 29 Feb 2016, Published online: 26 Mar 2016

References

  • Aslani P, Kennedy RA. 1996. Studies on diffusion in alginate gels. I. Effect of cross-linking with calcium or zinc ions on diffusion of acetaminophen. J Control Release. 42:75–82.
  • Baeten JM, Reid SE, Delany-Moretlwe S, Hughes JP, Wang RS, Wilcox E, et al. 2012. Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African women: a randomized, placebo-controlled trial. Sex Transm Dis. 39:21–24.
  • Bahrami G, Mirzaeei S, Kiani A. 2005. Determination of acyclovir in human serum by high-performance liquid chromatography using liquid-liquid extraction and its application in pharmacokinetic studies. J Chromatogr B Analyt Technol Biomed Life Sci. 816:327–331.
  • Boddu SH, Bonam SP, Wei Y, Alexander K. 2014. Preparation and in vitro evaluation of a pluronic lecithin organogel containing ricinoleic acid for transdermal delivery. Int J Pharm Compd. 18:256–261.
  • Bramwell BL, Williams LA. 2012. The use of Pluronic lecithin organogels in the transdermal delivery of drugs. Int J Pharm Compd. 16:62–63.
  • Bryson YJ, Dillon M, Lovett M, Acuna G, Taylor S, Cherry JD, et al. 1983. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N Engl J Med. 308:916–921.
  • Carcao MD, Lau RC, Gupta A, Huerter H, Koren G, King SM. 1998. Sequential use of intravenous and oral acyclovir in the therapy of varicella in immunocompromised children. Pediatr Infect Dis J. 17:626–631.
  • Collins P, Oliver NM. 1982. Acyclovir treatment of cutaneous herpes in guinea pigs and herpes encephalitis in mice. Am J Med. 73:96–99.
  • de Miranda P, Blum MR. 1983. Pharmacokinetics of acyclovir after intravenous and oral administration. J Antimicrob Chemother. 12:29–37.
  • Elia G, Camero M, Decaro N, Lovero A, Martella V, Tempesta M, Buonavoglia C, Crescenzo G. 2015. In vitro inhibition of caprine herpesvirus 1 by acyclovir and mizoribine. Res Vet Sci. 99:208–211.
  • Fu X, Yang Y, Wang N, Wang H, Yang Y. 2007. A novel chiral separation material: polymerized organogel formed by chiral gelators for the separation of D- and L-phenylalanine. J Mol Recognit. 20:238–244.
  • Jwala J, Boddu SH, Shah S, Sirimulla S, Pal D, Mitra AK. 2011. Ocular sustained release nanoparticles containing stereoisomeric dipeptide prodrugs of acyclovir. J Ocul Pharmacol Ther. 27:163–172.
  • Kantaria S, Rees GD, Lawrence MJ. 1999. Gelatin-stabilised microemulsion-based organogels: rheology and application in iontophoretic transdermal drug delivery. J Control Release. 60:355–365.
  • Kern ER, Richards JT, Overall JC, Jr, Glasgow LA. 1983. Acyclovir treatment of experimental genital herpes simplex virus infections. I. Topical therapy of type 2 and type 1 infections of mice. Antiviral Res. 3:253–267.
  • Kirilov P, Rum S, Gilbert E, Roussel L, Salmon D, Abdayem R, et al. 2014. Aqueous dispersions of organogel nanoparticles – potential systems for cosmetic and dermo-cosmetic applications. Int J Cosmet Sci. 36:336–346.
  • Kogan A, Garti N. 2006. Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci. 123–126:369–385.
  • Mahjour M, Mauser B, Rashidbaigi Z, Fawzi MB. 1990. Effect of egg yolk lecithins and commercial soybean lecithins on in vitro skin permeation of drugs. J Control Release. 14:243–252.
  • Marr PC, McBride K, Evans RC. 2013. Sugar-derived organogels as templates for structured, photoluminescent conjugated polymer-inorganic hybrid materials. Chem Commun (Camb). 49:6155–6157.
  • Mitchell C, Gentry S, Boen J, Bean B, Groth K, Balfour H. Jr. 1981. Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lancet. 1:1389–1392.
  • Mohanty B, Bohidar HB. 2005. Microscopic structure of gelatin coacervates. Int J Biol Macromol. 36:39–46.
  • Monavari SH, Mirzaei Parsa MJ, Bolouri B, Ebrahimi SA, Ataei-Pirkooh A. 2014. The inhibitory effect of Acyclovir loaded nano-niosomes against herpes simplex virus type-1 in cell culture. Med J Islam Repub Iran. 28:99.
  • Murdan S, Gregoriadis G, Florence AT. 1999a. Inverse toroidal vesicles: precursors of tubules in sorbitan monostearate organogels. Int J Pharm. 183:47–49.
  • Murdan S, Gregoriadis G, Florence AT. 1999b. Novel sorbitan monostearate organogels. J Pharm Sci. 88:608–614.
  • Murdan S, van den Bergh B, Gregoriadis G, Florence AT. 1999c. Water-in-sorbitan monostearate organogels (water-in-oil gels). J Pharm Sci. 88:615–619.
  • Muthukumar M. 1989. Screening effect on viscoelasticity near the gel point. Macromolecules. 22:4656–4658.
  • Panigrahi L, Pattnaik S, Ghosal SK. 2005. The effect of pH and organic ester penetration enhancers on skin permeation kinetics of terbutaline sulfate from pseudolatex-type transdermal delivery systems through mouse and human cadaver skins. AAPS PharmSciTech. 6:E167–E173.
  • Peacock GF, Sauvageot J, Addo RT. 2014. Evaluation of the stability of ketoprofen in pluronic lecithin organogel and the determination of an appropriate beyond-use date. Int J Pharm Compd. 18:348–350.
  • Pefile SC, Smith EW, Albrecht CF, Kruger PB. 1998. Release of rooperol tetra-acetate from topical bases: in vitro studies using silicone membrane. Int J Pharm. 161:237–243.
  • Peppas NA, Brannon-Peppas L. 1994. Water diffusion and sorption in amorphous macromolecular systems and foods. J Food Eng. 22:189–210.
  • Pisal S, Shelke V, Mahadik K, Kadam S. 2004. Effect of organogel components on in vitro nasal delivery of propranolol hydrochloride. AAPS PharmSciTech. 5:e63.
  • Quellet C, Eicke HF. 1986. Mutual gelation of gelatin and waterin-oil microemulsion. Chimia. 40:233–238.
  • Ritger PL, Peppas NA. 1987. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Control Release. 5:37–42.
  • Rizkov D, Mizrahi S, Cohen S, Lev O. 2010. beta-Amino alcohol selectors for enantioselective separation of amino acids by ligand-exchange capillary zone electrophoresis in a low molecular weight organogel. Electrophoresis. 31:3921–3927.
  • Sagiri SS, Singh VK, Kulanthaivel S, Banerjee I, Basak P, Battachrya MK, Pal K. 2015. Stearate organogel-gelatin hydrogel based bigels: physicochemical, thermal, mechanical characterizations and in vitro drug delivery applications. J Mech Behav Biomed Mater. 43:1–17.
  • Saket MM, James KC, Kellaway IW. 1984. Partitioning of some 21-alkyl esters of hydrocortisone and cortisone. Int J Pharm. 21:155–166.
  • Sallam MA, Motawaa AM, Mortada SM. 2015. An insight on human skin penetration of diflunisal: lipogel versus hydrogel microemulsion. Drug Dev Ind Pharm. 41:141–147.
  • Scartazzini R, Luisi PL. 1988. Organogels from lecithins. J Phys Chem. 92:829–833.
  • Swaika A, Paulus A, Miller KC, Sher T, Almyroudis NG, Ball D, et al. 2012. Acyclovir prophylaxis against varicella zoster virus reactivation in multiple myeloma patients treated with bortezomib-based therapies: a retrospective analysis of 100 patients. J Support Oncol. 10:155–159.
  • Upadhyay KK, Tiwari C, Khopade AJ, Bohidar HB, Jain SK. 2007. Sorbitan ester organogels for transdermal delivery of sumatriptan. Drug Dev Ind Pharm. 33:617–625.
  • Wagstaff AJ, Faulds D, Goa KL. 1994. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 47:153–205.
  • Yu H, Huang Q. 2012. Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions. J Agric Food Chem. 60:5373–5379.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.